Literature DB >> 7848542

Antiendotoxin monoclonal antibodies. What future now?

G M Susla1, R B Dew.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7848542     DOI: 10.2165/00002018-199411040-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  53 in total

1.  Anti-endotoxin monoclonal antibodies.

Authors:  H S Warren; R L Danner; R S Munford
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

Review 2.  Septic shock: pathogenesis.

Authors:  M P Glauser; G Zanetti; J D Baumgartner; J Cohen
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

3.  The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.

Authors:  M N Marra; C G Wilde; M S Collins; J L Snable; M B Thornton; R W Scott
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

Review 4.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

5.  Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock.

Authors:  R L Danner; C Natanson; R J Elin; J M Hosseini; S Banks; T J MacVittie; J E Parrillo
Journal:  Chest       Date:  1990-12       Impact factor: 9.410

6.  Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

Authors:  R V McCloskey; R C Straube; C Sanders; S M Smith; C R Smith
Journal:  Ann Intern Med       Date:  1994-07-01       Impact factor: 25.391

7.  Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factor.

Authors:  H S Warren; G R Riveau; F A de Deckker; L A Chedid
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

8.  Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock.

Authors:  C Natanson; R L Danner; R J Elin; J M Hosseini; K W Peart; S M Banks; T J MacVittie; R I Walker; J E Parrillo
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

9.  Lipopolysaccharides: structural principles and biologic activities.

Authors:  O Lüderitz; K Tanamoto; C Galanos; G R McKenzie; H Brade; U Zähringer; E T Rietschel; S Kusumoto; T Shiba
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug

10.  STUDIES ON BACILLUS TYPHOSUS TOXIC SUBSTANCES : I. PHENOMENON OF LOCAL SKIN REACTIVITY TO B. TYPHOSUS CULTURE FILTRATE.

Authors:  G Shwartzman
Journal:  J Exp Med       Date:  1928-07-31       Impact factor: 14.307

View more
  1 in total

Review 1.  New peptide and protein drugs.

Authors:  P Vermeij; D Blok
Journal:  Pharm World Sci       Date:  1996-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.